Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: MOLECULAR EXPRESS, INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-07-01 to 2023-06-30
Current total value of award: $300000
Description: THE CONTRACTOR SHALL TO ENGINEER NOVEL HIV GP41 ECTODOMAIN ANTIGENS (HIV GP41E-HD) FOR THE INCORPORATION INTO THE IMMUNOGENIC VESIVAX FORMULATIONS.